Audentes Therapeutics, Inc.
Biotechnology company · San Francisco, California, United States
Audentes Therapeutics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $65 million sold in a notice filed in 2015.
Audentes Therapeutics at a glance
What does Audentes Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $65 million sold (2015).
Frequently asked questions about Audentes Therapeutics
Where is Audentes Therapeutics headquartered?
Audentes Therapeutics, Inc. is headquartered in San Francisco, California, United States.
What does Audentes Therapeutics do?
Audentes Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Audentes Therapeutics founded?
The earliest incorporation on record for Audentes Therapeutics, Inc. is in 2012, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences